Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heparin for Septic Shock
NCT01234285Phase 2Withdrawn
- Sponsor
- University of Colorado Denver
- Start
- Dec 2010
- Primary completion
- Apr 2013
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of heparin in sepsis, sponsored by University of Colorado Denver. Planned start Dec 2010; status: withdrawn.
02
Drugs
heparin
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT01234285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01234285.